Walvax Biotechnology Co., Ltd. (SHE:300142)
12.85
+0.90 (7.53%)
Apr 28, 2026, 3:12 PM CST
26.73% (1Y)
| Market Cap | 20.55B +11.2% |
| Revenue (ttm) | 2.40B -10.6% |
| Net Income | 285.77M +118.7% |
| EPS | 0.18 +115.5% |
| Shares Out | 1.60B |
| PE Ratio | 72.42 |
| Forward PE | 70.41 |
| Dividend | 0.16 (1.30%) |
| Ex-Dividend Date | Jan 9, 2026 |
| Volume | 163,889,403 |
| Average Volume | 45,290,877 |
| Open | 11.90 |
| Previous Close | 11.95 |
| Day's Range | 11.90 - 13.61 |
| 52-Week Range | 9.85 - 14.65 |
| Beta | 0.47 |
| RSI | 58.01 |
| Earnings Date | Apr 28, 2026 |